Massive purchase at $IMCR
We have reported on large purchases before, but this time it's an exceptionally unusual one!
A senior executive at $IMCR purchased shares worth a massive $24 million
A move that increased his stake in the company's shares by no less than 60%!
$IMCR is a biotechnology company specializing in the development of innovative treatments for the immune system, with an emphasis on groundbreaking medical research.
When a director invests such an amount in the company's shares, it's an interesting sign that definitely makes us follow!
What does he know that we don't?
We are following!